Search research articles
Contact Us
Filters
Showing results (241-250 of 305) with videos related to
Page
of 31
Sort By:
Antiviral Research
|
January 31, 2025
High HIV-1 viremia and low anti-Env antibody responses are associated with delayed treatment response to fostemsavir in highly treatment-experienced individuals
Svenja Weiss, Raymond A Alvarez, Marisa Goff, et al.
Bioinformatics (Oxford, England)
|
July 29, 2011
RseqFlow: workflows for RNA-Seq data analysis
Ying Wang, Gaurang Mehta, Rajiv Mayani, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
May 27, 2022
Effects of Exercise and Sleep Deprivation on Reaction Severity During Oral Peanut Challenge: A Randomized Controlled Trial
Shelley Dua, Monica Ruiz-Garcia, Simon Bond, et al.
Plos One
|
August 11, 2011
Biologic phenotyping of the human small airway epithelial response to cigarette smoking
Ann E Tilley, Timothy P O'Connor, Neil R Hackett, et al.
The Lancet. Infectious Diseases
|
February 11, 2024
Chikungunya seroprevalence, force of infection, and prevalence of chronic disability after infection in endemic and epidemic settings: a systematic review, meta-analysis, and modelling study
Hyolim Kang, Megan Auzenbergs, Hannah Clapham, et al.
Mbio
|
April 27, 2022
Temsavir Treatment of HIV-1-Infected Cells Decreases Envelope Glycoprotein Recognition by Broadly Neutralizing Antibodies
Marianne Boutin, Dani Vézina, Shilei Ding, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
June 1, 2020
Cost-effectiveness of introducing a domestic pneumococcal conjugate vaccine (PCV7-TT) into the Cuban national immunization programme
Anai García Fariñas, Nivaldo Linares-Pérez, Andrew Clark, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
November 30, 2020
Corrigendum to "Cost-effectiveness of introducing a domestic pneumococcal conjugate vaccine (PCV7-TT) into the Cuban national immunization programme" [Int. J. Infect. Dis. 97 (2020) 182-189]
Anai García Fariñas, Nivaldo Linares-Pérez, Andrew Clark, et al.
Vaccines
|
June 28, 2023
Impact and Cost-Effectiveness of Alternative Human Papillomavirus Vaccines for Preadolescent Girls in Mozambique: A Modelling Study
Esperança Lourenço Guimarães, Assucênio Chissaque, Clint Pecenka, et al.
BMC Medicine
|
August 20, 2019
Guidelines for multi-model comparisons of the impact of infectious disease interventions
Saskia den Boon, Mark Jit, Marc Brisson, et al.
Page
of 31
Search research articles
Search
Showing results (241-250 of 305) with videos related to
Sort By:
Page
of 31
Antiviral Research
|
January 31, 2025
High HIV-1 viremia and low anti-Env antibody responses are associated with delayed treatment response to fostemsavir in highly treatment-experienced individuals
Svenja Weiss, Raymond A Alvarez, Marisa Goff, et al.
Bioinformatics (Oxford, England)
|
July 29, 2011
RseqFlow: workflows for RNA-Seq data analysis
Ying Wang, Gaurang Mehta, Rajiv Mayani, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
May 27, 2022
Effects of Exercise and Sleep Deprivation on Reaction Severity During Oral Peanut Challenge: A Randomized Controlled Trial
Shelley Dua, Monica Ruiz-Garcia, Simon Bond, et al.
Plos One
|
August 11, 2011
Biologic phenotyping of the human small airway epithelial response to cigarette smoking
Ann E Tilley, Timothy P O'Connor, Neil R Hackett, et al.
The Lancet. Infectious Diseases
|
February 11, 2024
Chikungunya seroprevalence, force of infection, and prevalence of chronic disability after infection in endemic and epidemic settings: a systematic review, meta-analysis, and modelling study
Hyolim Kang, Megan Auzenbergs, Hannah Clapham, et al.
Mbio
|
April 27, 2022
Temsavir Treatment of HIV-1-Infected Cells Decreases Envelope Glycoprotein Recognition by Broadly Neutralizing Antibodies
Marianne Boutin, Dani Vézina, Shilei Ding, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
June 1, 2020
Cost-effectiveness of introducing a domestic pneumococcal conjugate vaccine (PCV7-TT) into the Cuban national immunization programme
Anai García Fariñas, Nivaldo Linares-Pérez, Andrew Clark, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
November 30, 2020
Corrigendum to "Cost-effectiveness of introducing a domestic pneumococcal conjugate vaccine (PCV7-TT) into the Cuban national immunization programme" [Int. J. Infect. Dis. 97 (2020) 182-189]
Anai García Fariñas, Nivaldo Linares-Pérez, Andrew Clark, et al.
Vaccines
|
June 28, 2023
Impact and Cost-Effectiveness of Alternative Human Papillomavirus Vaccines for Preadolescent Girls in Mozambique: A Modelling Study
Esperança Lourenço Guimarães, Assucênio Chissaque, Clint Pecenka, et al.
BMC Medicine
|
August 20, 2019
Guidelines for multi-model comparisons of the impact of infectious disease interventions
Saskia den Boon, Mark Jit, Marc Brisson, et al.
Page
of 31